Have never been more excited about CYDY. Hoping fo
Post# of 148174
That being what it is, what do you think should qualify someone for the trial?
Imho, regardless of indication, LL is going to make a lot of people feel & perform much better. Placebo effect should be mute, as that will be shared.
I feel that even a large trial would enroll very quickly, if not too picky. If CYDY gets too specific, the "moving target" might come into play.
At this point, I like the opportunity to gather much data for multiple indications more than rolling the dice on just one. And the safety record just grows.
s/c is quite different, imho.
Your thoughts? Sorry, if this has already been discussed- then pay me no mind or mention.